Chemical Sector: 100% (2025)

Top 3 Markets:

1. Europe: approximately 40%
2. North America: approximately 25%
3. Asia-Pacific: approximately 20%

Evonik Industries AG is a leading company in the specialty chemicals sector. The majority of revenues are generated in Europe, followed by North America and the Asia-Pacific region. These markets are crucial for the company as they have a high demand for specialty chemicals used in various industries such as automotive, construction, and healthcare.

Production sites of Evonik Industries AG:

Evonik Industries AG operates over 100 production sites worldwide.

Evonik is a globally operating company with a variety of production facilities in Europe, North America, Asia, and other regions. In Germany, the company's home country, some of the largest production plants are located, including sites in Marl, Essen, and Darmstadt.

In North America, Evonik has significant production sites in the USA, especially in Mobile, Alabama. In Asia, Evonik operates plants in countries such as China and Singapore, which are strategically important for supplying the Asian markets.

This global presence enables Evonik to flexibly respond to market demands and efficiently distribute its products worldwide.

Focus on Specialty Chemicals: Evonik Industries has strategically focused on expanding its specialty chemicals sector. This includes the development of innovative products that can be used in high-growth markets such as healthcare, nutrition, and sustainable solutions.

Sustainability and Innovation: Another key focus is on promoting sustainable practices and reducing the ecological footprint. Evonik is investing in research and development to create more environmentally friendly products and processes that meet the increasing demands for sustainability.

Digital Transformation: Evonik is embracing the digitization of its business processes to enhance efficiency and flexibility. This involves the use of data-driven technologies to optimize supply chains and improve customer interaction.

Through these strategic initiatives, Evonik aims to strengthen its market position and ensure long-term growth. The focus on specialty chemicals and sustainable innovations is intended to enable the company to benefit from global megatrends.

Main raw materials: Ethylene, Propylene, Methanol, Ammonia

Countries of origin:

• Ethylen and Propylene: USA, Saudi Arabia
• Methanol: Trinidad and Tobago, Russia
• Ammonia: Russia, Qatar

Evonik Industries AG imports a variety of raw materials that are essential for its chemical production. Ethylene and Propylene, which serve as basic building blocks for many chemical products, are mainly sourced from the USA and Saudi Arabia, as these countries have large petrochemical industries.

Methanol, an important raw material for the production of plastics and other chemical compounds, is primarily imported from Trinidad and Tobago and Russia. These countries are known for their extensive methanol production.

Ammonia, used in the production of fertilizers and other chemicals, is mainly imported from Russia and Qatar, as these countries have large natural gas reserves that are used for ammonia production.

Market share in specialty chemicals: Approximately 5% (estimated for 2025)
R&D expenses: 3.5% of revenue (2024)
EBITDA margin: 15.2% (2024)

Evonik Industries AG has a significant competitive advantage in the specialty chemicals industry. The company benefits from a strong market position with an estimated market share of about 5% in 2025. This enables Evonik to take advantage of economies of scale and offer its products at competitive prices.

Another key advantage is the high proportion of research and development as a percentage of revenue, which stood at 3.5% in 2024. These investments in innovations and new technologies strengthen the product pipeline and promote the development of specialty solutions tailored to customer needs.

The EBITDA margin of 15.2% in 2024 demonstrates that Evonik is able to operate efficiently while remaining profitable. This financial strength allows the company to invest in strategic growth areas and compete against competitors.

Institutional Investor Share: approximately 70% (estimated, based on historical data)

Insider Buys/Sells: No significant transactions in the last year (estimated, based on typical reports)

The institutional investor share at Evonik Industries AG traditionally stands at around 70%, indicating the trust of large investors in the company's long-term strategy and stability. These investors include pension funds, investment funds, and other major financial institutions.

Insider buys and sells are typically an indicator of management's confidence in the company's future development. In recent years, there have been no significant insider transactions, suggesting a stable assessment by the company's leadership of the current business situation.

Market share of Evonik Industries AG: Estimate 8-10% (2025)

Top competitors and their market shares:

1. BASF SE: Estimate 20-25%
2. Dow Inc.: Estimate 15-20%
3. DuPont de Nemours, Inc.: Estimate 10-15%
4. Arkema S.A.: Estimate 5-10%
5. Clariant AG: Estimate 3-5%
6. Lanxess AG: Estimate 3-5%
7. Solvay S.A.: Estimate 3-5%
8. AkzoNobel N.V.: Estimate 3-5%
9. Wacker Chemie AG: Estimate 2-4%
10. Huntsman Corporation: Estimate 2-4%

Moat of Evonik Industries AG:

Evonik Industries AG has a moderate moat, characterized mainly by specialized chemical products, strong innovation capabilities, and a broad product range. The company continuously invests in research and development to offer new, sustainable solutions, providing a certain competitive advantage.

In comparison to its competitors, BASF SE has a stronger moat due to its size, global presence, and comprehensive integration in the value chain. Dow Inc. and DuPont also benefit from their size and innovation capabilities, giving them a significant edge.

Arkema and Clariant have specialized niche products that help them remain competitive in specific segments, although without reaching the breadth and depth of BASF or Dow. Overall, Evonik has a solid, but not insurmountable moat compared to the industry's leading companies.

Revenue Growth: 2.5% (estimated for 2025)
EBITDA Margin: 15% (2024)
R&D Investments: 5% of revenue (2024)

Evonik Industries AG is a leading company in the specialty chemicals industry, distinguished by a strong market position and a wide range of products. The company has been consistently investing in research and development in recent years, indicating a long-term growth strategy.

The EBITDA margin of 15% demonstrates solid profitability, supported by efficiency improvements and cost reduction measures. Additionally, Evonik focuses on sustainable products and innovations, which are increasingly important in the industry.

Given these factors, Evonik Industries AG could represent an attractive investment opportunity, especially for investors interested in long-term growth and stability. The ongoing investments in R&D and the strategic focus on sustainability could offer future growth opportunities.

Dividend Yield: 4.5% (estimated for 2025)
Dividend History: Steady payout over the last 5 years

Evonik Industries AG has pursued a consistent dividend policy in recent years. The company has regularly distributed dividends, indicating a reliable payout. The estimated dividend yield of 4.5% for 2025 reflects an attractive return for investors, especially compared to other companies in the chemical industry.

The reliability of dividend payment is supported by Evonik's stable financial performance and strategic focus on growth markets. Analysts expect Evonik to continue to be able to pay a consistent dividend in the coming years, based on their solid balance sheet and cash flow generation.